Skip to main content

Table 2 Factors affecting susceptibility/resistance to adjuvant arthritis

From: The determinants of susceptibility/resistance to adjuvant arthritis in rats

Effector pathways/response

Susceptibility/resistance (+/-)

Rat strains tested

References

MHC and non-MHC genes including particular quantitative trait loci influence arthritis susceptibility

+/-

Table 1

Table 1, [4, 5]

Differential T-cell proliferative and/or cytokine response to Bhsp65, its arthritogenic epitope 180 to 188, or its regulatory C-terminal determinants

+/-

LEW/WKY/Wistar/F344

[20, 24, 30, 31, 33, 36]

Increased T-cell response to Rhsp65 and its regulatory epitopes

-

LEW/WKY

[20, 24, 26]

Anti-Bhsp65/Rhsp65 antibody response induced upon Mtb challenge

-

LEW/BN/WKY/F344/Wistar

[23, 25, 43]

Increased expression of hsp47 in the joints and enhanced anti-hsp47 antibodies in rats with arthritis

+

DA/AO

[45]

Immune response to hsp71

-

DA/AO/LEW

[45, 46]

Migration into and retention within the target organ (joints) of arthritogenic leukocytes; the role of monocyte chemoattractant protein 1 and monocyte/macrophage chemotaxis

+

LEW/WKY

[19, 20]

Increased reactive oxygen species contributing to arthritis resistance

-

DA/AO

[10]

Blunted hypothalamic–pituitary–adrenal axis activity

+

LEW/F344/Wistar

[51, 53–55]

Microbial flora in a conventional housing environment

-

F344/Wistar

[56, 59, 60]

  1. Bhsp65, mycobacterial heat-shock protein 65; hsp, heat-shock protein; MHC, major histocompatibility complex; Mtb, Mycobacterium tuberculosis H37Ra; Rhsp65, rat heat-shock protein 65.